Valuation: Celltrion Pharm, Inc.

Market Cap 4,674B 6,191,554B 4,174B 3,856B 3,494B 6,537B 443,669B 6,645B 46,397B 18,369B 232,454B 17,540B 17,167B 732,861B P/E 2019
166x
P/E 2020 417x
Enterprise Value 4,837B 6,407,855B 4,319B 3,990B 3,616B 6,765B 459,168B 6,877B 48,018B 19,011B 240,574B 18,153B 17,767B 758,464B EV / Sales 2019
9.06x
EV / Sales 2020 38x
Free-Float
44.16%
Yield 2019 *
-
Yield 2020 -
1 day-2.59%
1 week-3.34%
Current month-1.31%
1 month-3.71%
3 months-6.93%
6 months-35.51%
Current year-35.17%
1 week 37,550
Extreme 37550
40,850
1 month 35,600
Extreme 35600
40,850
Current year 35,600
Extreme 35600
78,300
1 year 35,600
Extreme 35600
78,300
3 years 35,600
Extreme 35600
124,463.12
5 years 35,600
Extreme 35600
124,463.12
10 years 13,660.97
Extreme 13660.974887
221,035.48
Manager TitleAgeSince
Chief Executive Officer 61 26/03/2024
Director of Finance/CFO 53 -
Sales & Marketing 55 -
Director TitleAgeSince
Chairman 69 28/03/2025
Chairman 42 26/03/2024
Director/Board Member 61 26/03/2024
Date Insider Type Main position Quantity % Market Cap. Importance
7/5/25 Others 24 0.0001%
7/5/25 Others 127 0.0003%
7/5/25 Exercice 4,500 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
-2.59%-3.34%-32.24%-37.08% 1.25B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 635B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -1.24%+1.35%+30.09%+58.53% 400.49B
Weighted average by Cap. -1.35%+2.66%+41.00%+79.72%

Financials

2019 2020
Net sales 174B 229,865B 155B 143B 130B 243B 16,471B 247B 1,723B 682B 8,630B 651B 637B 27,208B 234B 309,425B 209B 193B 175B 327B 22,172B 332B 2,319B 918B 11,617B 877B 858B 36,625B
Net income 8.6B 11,396B 7.68B 7.1B 6.43B 12.03B 817B 12.23B 85.4B 33.81B 428B 32.28B 31.6B 1,349B 20.94B 27,740B 18.7B 17.27B 15.65B 29.29B 1,988B 29.77B 208B 82.3B 1,041B 78.58B 76.91B 3,283B
Net Debt 149B 196,799B 133B 123B 111B 208B 14,102B 211B 1,475B 584B 7,389B 558B 546B 23,294B 163B 216,300B 146B 135B 122B 228B 15,499B 232B 1,621B 642B 8,121B 613B 600B 25,602B
Logo Celltrion Pharm, Inc.
Celltrion Pharm Inc is a Korea-based company engaged in the manufacture and sale of pharmaceuticals. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. It also provides ethical drugs and over-the-counter (OTC) drugs. The Company distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.
Employees
328
Date Price Change Volume
23/10/26 ₩37,600.00 -2.59% 44,351
22/10/26 ₩38,600.00 -1.91% 59,209
21/10/26 ₩39,350.00 -0.13% 49,244
20/10/26 ₩39,400.00 -1.50% 61,227
19/10/26 ₩40,000.00 +2.83% 48,649
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. A068760 Stock